Redox signaling (Anna-Liisa Levonen group)

Nrf2 is a transcription factor mainly involved in combating cellular stress caused by reactive oxygen and nitrogen species. However, Nrf2 is also involved in cancer and cardiometabolic diseases, making it an essential drug target.

Rilla Lab

The discovery of the role of extracellular vesicles (EV) as specific communicators between the cells and the extracellular matrix has changed our understanding of human physiology. These tiny plasma membrane-derived particles are like fingerprints from the original cells. They carry a similar set...

Vascular Biology (Laakkonen)

'From basic science to translational impact.'
The goal of our junior research group is to improve therapeutics and diagnostics of cardiovascular diseases by understanding the biology behind the diseases. The main focus is in studying vascular anomalies and aortic aneurysms. Particularly ...

GeneCellNano Flagship

01.07.2020 - 31.12.2024
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
<...

Diana Schenkwein

Senior Researcher , A.I. Virtanen Institute for Molecular Sciences